Friday, January 2, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

EFTR Trading Halt Lifted After Pending News Release

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Finances
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

At 8:55:00 AM ET on March 11, 2024, the trading halt on EFTR was lifted, allowing quotations to resume. This pause was necessary due to pending important news or regulatory issues, which could result in higher volatility once trading resumed. The trading halt was officially lifted at 8:55:00 AM ET, with quotation resumption times adjusted accordingly after the news was released.

LM Funding America, Inc. (LMFA) Stock Surges 30% on March 12, 2024: What Investors Need to Know

On March 12, 2024, LM Funding America, Inc. (LMFA) saw a significant increase in its stock performance. LMFA is currently trading in the middle of its 52-week range and above its 200-day simple moving average, indicating a relatively stable position in terms of its long-term performance.

The price of LMFA shares increased by $0.13 since the market last closed, representing a 30.27% rise in the stock price to $0.57. In pre-market trading, LMFA saw a further increase of $2.85 in its stock price.

This surge in LMFA’s stock performance could be attributed to positive news or developments related to the company, changes in market conditions, or increased investor interest. Investors who held LMFA shares likely saw a significant increase in the value of their investment on this day.

Stock prices are volatile and subject to fluctuations based on various factors. Investors should conduct thorough research, consider their risk tolerance, and consult with a financial advisor before making investment decisions. The strong performance of LMFA on March 12, 2024, highlights the potential for gains in the stock market and the risks associated with investing in individual stocks.

LMFA Stock Performance Review: Decline in Revenue and Net Income, Investors Await Turnaround

LMFA stock had a mixed performance on March 12, 2024, as the company reported its financial results for the past year and the third quarter. According to data from CNN Money, LMFA’s total revenue for the past year was $1.67 million, which represented an 88.64% decrease compared to the previous year. However, the total revenue for the third quarter was $3.42 million, showing a 7.06% increase compared to the previous quarter.

In terms of net income, LMFA reported a net loss of $29.24 million for the past year, which was a significant decrease of 714.39% compared to the previous year. However, the net loss for the third quarter was $4.42 million, showing a 2.91% increase compared to the previous quarter.

Earnings per share (EPS) for LMFA also saw a decline over the past year. The EPS for the past year was -$2.23, which represented a 472.22% decrease compared to the previous year. However, the EPS for the third quarter was -$0.33, showing a 5.04% increase compared to the previous quarter.

Investors will be closely monitoring LMFA’s future financial results to see if the company can turn around its performance and drive growth in the coming quarters.

Tags: LMFA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Market Today (1)

Revolutionizing CAR T Therapy A Groundbreaking Global Gene Editing Licensing Agreement

DrugRetailers Stock Exchange

Analysts Bullish on Academy Sports with Strong Buy Consensus

Vail Resorts Faces Setbacks in Q2 Financial Results

Recommended

AMD Stock

AMD Secures Landmark AI Partnership with OpenAI

1 month ago
Appian Stock

Institutional Investors Divided on Appian’s Low-Code Future

4 months ago
Metaplanet Stock

Metaplanet’s Bold Bitcoin Strategy Fuels Stock Surge in Tokyo

3 weeks ago
ASML Stock

ASML’s Strategic Balancing Act: Navigating Geopolitics and Technological Dominance

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Legal Challenge Casts Shadow Over DeFi Technologies’ Growth Narrative

Strategy Faces Potential Index Exclusion Over Bitcoin Holdings

BioNxt Solutions: Clinical Milestones Set to Define 2026 Trajectory

TSMC Strengthens Market Dominance with Dual Technological and Geopolitical Wins

CureVac Acquisition Enters Final Phase as BioNTech Integration Accelerates

Institutional Investors Show Diverging Views on Johnson & Johnson Stock

Trending

Bitcoin Stock
Bitcoin

Bitcoin’s 2026 Crossroads: Consolidation or Breakout?

by Robert Sasse
January 2, 2026
0

As 2026 gets underway, Bitcoin finds itself in a state of constrained trading, caught between conflicting capital...

Novo Nordisk Stock

Novo Nordisk Faces Strategic Crossroads Amid Pipeline Setback and New Launch

January 2, 2026
Oxford Lane Capital Stock

Analyzing Oxford Lane Capital’s High-Yield Dividend Strategy for 2026

January 2, 2026
DeFi Technologies Stock

Legal Challenge Casts Shadow Over DeFi Technologies’ Growth Narrative

January 2, 2026
Strategy Stock

Strategy Faces Potential Index Exclusion Over Bitcoin Holdings

January 2, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Bitcoin’s 2026 Crossroads: Consolidation or Breakout?
  • Novo Nordisk Faces Strategic Crossroads Amid Pipeline Setback and New Launch
  • Analyzing Oxford Lane Capital’s High-Yield Dividend Strategy for 2026

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com